Left Main Coronary Artery Disease: CABG is superior to PCI
DOI:
https://doi.org/10.2015/hc.v7i1%20Sup.504Keywords:
Left main coronary artery disease, CABG, PCIAbstract
Left main coronary artery disease (LMCAD) is a special part of coronary pathology and its gold standard treatment is coronary artery bypass surgery (CABG). Over the last two decades, the evolution in technology and materials and the growing experience of interventional cardiologist treating acute coronary syndrome improved the results of percutaneous coronary interventions even in patients with LM disease. Recent prospective randomized studies though (SYNTAX) as well as large registries comparing the two methods showed comparable results concerning safety and inferiority of PCI regarding restenosis and need for reintervention. Up to now CABG remains the treatment of choice for LM disease with PCI being a reliable alternative solution in cases of patients of high surgical risk. The above is strongly recommended by the new guidelines.Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).